1. 134 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LOWER RISK MDS PATIENTS : A RETROSPECTIVE STUDY ON BEHALF OF THE CMWP OF THE EBMT. (April 2015) Authors: Robin, M.; Porcher, R.; Zinke, W.; Van Biezen, A.N.J.A.; Volin, L.; Mufti, G.; Craddock, C.; Finke, J.; Richard, C.; Passweg, J.; Peniket, A.; Martens, J.; Sucak, G.; Gedde-Dahk, T.; Vitek, A.; Nagler, A.; Blaise, D.; Beelen, D.; Maillard, N.; Schwerdtfeger, R. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients. (19th September 2017) Authors: Matin, R.N.; Danby, R.; Gibbons, E.; Venning, V.; Rowley, L.; Barton, D.; Pawson, R.; Littlewood, T.; Reed, J.R.; Peniket, A. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients. (1st December 2017) Authors: Matin, R.N.; Danby, R.; Gibbons, E.; Venning, V.; Rowley, L.; Barton, D.; Pawson, R.; Littlewood, T.; Reed, J.R.; Peniket, A. Journal: British journal of dermatology Issue: Volume 177:Number 6(2017) Page Start: 1758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Provision of cellular blood components to CMV‐seronegative patients undergoing allogeneic stem cell transplantation in the UK: survey of UK transplant centres. Issue 6 (15th September 2017) Authors: Morton, S.; Peniket, A.; Malladi, R.; Murphy, M. F. Journal: Transfusion medicine Issue: Volume 27:Issue 6(2017:Dec.) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Transfusion in CMV seronegative T‐depleted allogeneic stem cell transplant recipients with CMV‐unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience. Issue 6 (26th June 2015) Authors: Hall, S.; Danby, R.; Osman, H.; Peniket, A.; Rocha, V.; Craddock, C.; Murphy, M.; Chaganti, S. Journal: Transfusion medicine Issue: Volume 25:Issue 6(2015) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Transfusion of CMV‐unselected blood components may lead to inappropriate donor selection for patients subsequently undergoing allogeneic stem cell transplant. Issue 6 (December 2015) Authors: Morton, S.; Danby, R.; Rocha, V.; Peniket, A.; Murphy, M. F. Journal: Transfusion medicine Issue: Volume 25:Issue 6(2015) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗